Eli Lilly: Still Expensive As Earnings Near, But Not Worthy Of A Downgrade
Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.
Tri-Central senior earns Lilly scholarship
Tri-Central High School senior Kaitlyn Maruszewski was named the Tipton County recipient of the 2025 Lilly Endowment Community Scholarship. The scholarship equals a full ride to college. Each Lilly ...
Eli Lilly: Still Much Room To Ride The Weight-Loss Wave
Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...
Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn
Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...
ENDPOINTS NEWS21h
Lil­ly fi­nances new $500M biotech fund man­aged by a16z
Eli Lilly is expanding its private financing ambitions, partnering with venture capital firm Andreessen Horowitz on a new ...
WOWO22h
Indiana Economic Development Continues to Break Records
Indiana Governor Eric J. Holcomb and Indiana Secretary of Commerce David Rosenberg today highlighted the 2024 economic ...
Andreessen Horowitz, Eli Lilly to launch $500 million venture fund
Venture capital firm Andreessen Horowitz said on Friday it was working with Eli Lilly to launch a $500 million venture fund that will be fully funded by the U.S. drugmaker. WHY IT'S IMPORTANT The fund ...